Cargando…
Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus
INTRODUCTION: The safety and efficacy of pembrolizumab administration in patients with urothelial carcinoma and underlying autoimmune disease (including overlap syndrome) is unknown. CASE PRESENTATION: We present the case of a 67‐year‐old woman with cT3N2M0 metastatic renal pelvic cancer who had bee...
Autores principales: | Kurokawa, Masayuki, Naito, Sei, Ito, Suguru, Takai, Satoshi, Kawamura, Yuko, Kaneko, Hisashi, Kakizaki, Hiroshi, Tsuchiya, Norihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469821/ https://www.ncbi.nlm.nih.gov/pubmed/32914068 http://dx.doi.org/10.1002/iju5.12175 |
Ejemplares similares
-
Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus
por: Hatakeyama, Shingo, et al.
Publicado: (2020) -
Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis
por: Dey, Biswajit, et al.
Publicado: (2020) -
Ayurvedic Management of Systemic Lupus Erythematosus overlap Vasculitis
por: Gururaja, D., et al.
Publicado: (2019) -
A Case of Systemic Lupus Erythematosus/Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome with Dissociated Pathological and Immunological Findings
por: Kato, Kazuhiko, et al.
Publicado: (2020) -
Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
por: Guleria, Vivek S., et al.
Publicado: (2014)